Abstract:Objectives Carbapenem-resistant Enterobacteriaceae is increasingly recognised as a significant public health concern. Ceftazidime-avibactam (CAZ-AVI) and polymyxins are considered as the last therapeutic options worldwide. This is the first meta-analysis of recently published data to compare the clinical efficacy and safety of CAZ-AVI with polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections. Design Systematic review and meta-analysis. Data sources PubMed, Embase and the Cochrane Library were systematically searched, for publications in any language, from database inception to February 2023. Eligibility criteria for selecting studies Studies comparing the clinical efficacy and safety of CAZ-AVI with polymyxins were included. Mortality, clinical success, microbiological eradication and nephrotoxicity were assessed as the main outcomes. Data extraction and synthesis Literature screening, data extraction and the quality evaluation of studies were conducted by two researchers independently, with disagreements resolved by another researcher. The Newcastle–Ottawa Scale was used to assess the bias risk for the included studies. Review Manager V.5.3 was employed for the meta-analysis. Results The meta-analysis included seven retrospective and four prospective cohort studies with 1111 patients enrolled. The CAZ-AVI groups demonstrated a lower 30-day mortality (risk ratio (RR)=0.48, 95% CI of 0.37 to 0.63, I 2 =10%, p<0.0001) in nine studies with 766 patients; higher clinical success (RR=1.71, 95% CI 1.33 to 2.20, I 2 =35%, p<0.0001) in four studies with 463 patients; and lower nephrotoxicity in seven studies with 696 patients (RR=0.42, 95% CI 0.23 to 0.77, I 2 =35%, p<0.05). However, no significant difference in microbiological eradication rates was observed in 249 patients from two studies (RR=1.16, 95% CI 0.97 to 1.39, I 2 =0, p>0.05). Conclusion Available evidence suggested that CAZ-AVI treatment held a dominant position with respect to efficacy and safety compared with polymyxins in carbapenem-resistant Enterobacteriaceae infections. However, the analysis included only observational studies, and high-quality, large-scale, multicentre, double-blind randomised controlled trials are needed to confirm the advantage of CAZ-AVI.

A randomized controlled study on cefpirome versus ceftazidime in the treatment of bacterial infections

A multicenter study on the in vitro antibacterial activity of cefoselis against common clinical bacteria

A Randomized Controlled Study of Cefoperazone-Tazobactam Versus Cefoperazone-Sulbactam in the Treatment of Bacterial Infections

Ceftazidime/Avibactam versus Polymyxin B in the Challenge of Carbapenem-Resistant <i>Pseudomonas</i> aeruginosa Infection

Efficacy and Safety of Ceftazidime–avibactam Versus Polymyxins in the Treatment of Carbapenem-Resistant Enterobacteriaceae Infection: a Systematic Review and Meta-Analysis

Multicenter randomized controlled clinical study of cefdinir and cefteram

A randomized comparative study of gatifloxacin and ciprofloxacin in the treatment of bacterial infections

Clinical Study of Cefprozil in Treatment of Respiratory Tract Infections

An open label clinical trial on cefpiramide in the treatment of acute bacterial infection

Clinical Study for Cefepine in the Treatment of Moderate and Severe Bacterial Infections

Multi-center, randomized, blinded, parallel control clinical study of cefazedone injection and cefazolin injection in the treatment of acute bacterial respiratory infections

Pharmacoeconomics on Treatment of Gram-Negative Bacteria Infections with Cefoperazone-Sulbactam, Imipenem-Cilastatin, and Piperacillin-Tazobactam

A Randomized Multicenter Clinical Study of Cefpodoxime Proxetil Tablets in Treatment of Acute Bacterial Infections in 158 Patients

Comparative study on cefprozil and cefaclor in the treatment of respiratory tract infections

Randomized Controlled Multicentric Clinical Trial of Domestic and Imported Cefepime in the Treatment of Acute Urinary Infections

Treatment of Moderate and Severe Infection with Ticarcillin/clavulanic Acid Versus Ceftazidime in 41 Patients

Clinical Comparative Study of Injectable Azithromycin and Cefuroxime in the Treatment of Lower Respiratory Tract Infection

A Randomized Controlled Study of Domestic and Imported Cefotiam in the Treatment of Bacterial Infections

A Randomized Controlled Clinical Trial of Piperacillin/Tazobactam Versus Imipenem/Cilastatin in the Treatment of Bacterial Infections

A Randomized Controlled Clinical Study on Levofloxacin Versus Ciprofloxacin in the Treatment of Bacterial Infections

Clinical Efficacy and Safety Evaluation of Cefdinir in the Treatment of Skin and Soft Tissue Bacterial Infections